Andrew S Kraft

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Science immunology

Cancer

The Journal of cell biology

EMBO reports

University of Arizona

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Arizona Sep 12 2014

United States

Associate Director of Basic Sciences :: Cancer Center

Publications

Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang, Jiazhuo Yan, Tingting Tang, Tasha Barr, Andrew S Kraft, Michael A Caligiuri, Jian Hua Yu
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells. Science immunology 8 (81) (2023)
Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang, Jiazhuo Yan, Tingting Tang, Tasha Barr, Andrew S Kraft, Michael A Caligiuri, Jian Hua Yu
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells. Science immunology 8 (81) (2023)
Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang, Jiazhuo Yan, Tingting Tang, Tasha Barr, Andrew S Kraft, Michael A Caligiuri, Jian Hua Yu
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells. Science immunology 8 (81) (2023)
Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang, Jiazhuo Yan, Tingting Tang, Tasha Barr, Andrew S Kraft, Michael A Caligiuri, Jian Hua Yu
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells. Science immunology 8 (81) (2023)
Shoubao Ma, Jingjing Han, Zhenlong Li, Sai Xiao, Jianying Zhang, Jiazhuo Yan, Tingting Tang, Tasha Barr, Andrew S Kraft, Michael A Caligiuri, Jian Hua Yu
An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells. Science immunology 8 (81) (2023)
Corbin C Jensen, Amber N Clements, Hope Liou, Lauren E Ball, Jennifer R Bethard, Paul R Langlais, Rachel K Toth, Shailender S Chauhan, Andrea L Casillas, Sohail R Daulat, Andrew S Kraft, Anne E Cress, Cindy K Miranti, Ghassan Mouneimne, Gregory C Rogers, Noel A Warfel
PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. The Journal of cell biology 222 (6) (2023)
Julio Alvarenga Thiebaud, Vinod Ravi, Samuel Litwin, Scott M Schuetze, Sujana Movva, Mark Agulnik, Andrew S Kraft, Eric D Tetzlaff, Neeta Somaiah, Margaret von Mehren
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer 128 (19) (2022)
Neha Singh, Varune R Ramnarine, Jin H Song, Ritu Pandey, Sathish K R Padi, Mannan Nouri, Virginie Olive, Maxim Kobelev, Koichi Okumura, David McCarthy, Michelle M Hanna, Piali Mukherjee, Belinda L Sun, Benjamin R Lee, J Brandon Parker, Debabrata Chakravarti, Noel A Warfel, Muhan Zhou, Jeremiah J Bearss, Ewan A Gibb, Mohammed Alshalalfa, R Jefferey Karnes, Eric J Small, Rahul R Aggarwal, Felix Y Feng, Yuzhuo Z Wang, Ralph Buttyan, Amina Zoubeidi, Mark A Rubin, Martin Gleave, Frank J Slack, Elai Davicioni, Himisha Beltran, Colin Collins, Andrew S Kraft
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nature communications 12 (1) (2021)
Jeremiah J Bearss, Sathish K R Padi, Neha Singh, Marina Cardo-Vila, Jin H Song, Ghassan Mouneimne, Nikita Fernandes, Yang Li, Matthew R Harter, Jaime Mc Gard, Anne E Cress, Wolfgang Peti, Andrew Dl Nelson, J Ross Buchan, Andrew S Kraft, Koichi Okumura
EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics. EMBO reports 22 (4) (2021)
Neeta Somaiah, Brian Andrew Van Tine, Amy E Wahlquist, Mohammed M Milhem, Elizabeth G Hill, Elizabeth Garrett-Mayer, Kent E Armeson, Scott M Schuetze, Christian F Meyer, Daniel Y Reuben, Anthony D Elias, William L Read, Sant P Chawla, Andrew S Kraft
A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma. Cancer 127 (6) (2020)
James T Lim, Neha Singh, Libia A Leuvano, Valerie S Calvert, Emanuel F Petricoin, David T Teachey, Richard B Lock, Sathish K R Padi, Andrew S Kraft
PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis. Molecular cancer therapeutics 19 (9) (2020)
Neha Singh, Sathish K R Padi, Jeremiah J Bearss, Ritu Pandey, Koichi Okumura, Himisha Beltran, Jin H Song, Andrew S Kraft, Virginie Olive
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth. Molecular oncology 14 (5) (2020)

Andrew S Kraft.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew S Kraft